Life Science 2.0: reframing the life science sector for 'the benefit on mankind'
The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. However, we saw that the fruits of science were inequitably distributed. Most low- and middle-income count...
Saved in:
Main Authors: | Michaela Vallin (Author), Göran Tomson (Author), Beate Kampmann (Author), Eivind Engebretsen (Author), Stefan Swartling Peterson (Author), Rhoda K. Wanyenze (Author), Ole Petter Ottersen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine Inequities, Intellectual Property Rights and Pathologies of Power in the Global Response to COVID-19
by: Eivind Engebretsen, et al.
Published: (2022) -
The Cradle of Mankind; Life in Eastern Kurdistan
by: Wigram, Edgar Thomas Ainger, 1864-1935; Wigram, W. A. (William Ainger), 1872-1953 -
Paradoxes of sustainability with consequences for health
by: Eivind Engebretsen, et al.
Published: (2016) -
New Directions in Global Health: How Sweden Can Advance Healthier Populations
by: Simon Holmesson, et al.
Published: (2022) -
Reframing implementation science to address inequities in healthcare delivery
by: Ana A. Baumann, et al.
Published: (2020)